Cited by 366Health Systems, Economic Evaluations, Quality of LifeMeta-analysis and systematic reviewsDelphi Technique in Research

The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Open access

Ofman, Joshua J., Sullivan, Sean D., Neumann, Peter J., Chiou, Chiun-Fang, Henning, James M., Wade, Sally W., Hay, Joel W.·2003·Journal of Managed Care Pharmacy

DOI 10.18553/jmcp.2003.9.1.53PMC PMC10437166

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODS: We first reviewed secondary references to examine ways in which health economic analyses are used in different health care settings, the manner in which these data are appraised and evaluated, and their relevance and value in decision making. The QHES, a new instrument designed to support fast, accurate initial assessments of study quality, was then introduced and validated. A case study was performed using the QHES to score the quality of 30 cost-effectiveness studies in gastroesophageal reflux disease (GERD) published since 1985. Areas where additional research could guide efforts to identify and enhance the use of higher-quality cost-effectiveness studies were suggested. RESULTS: Results from the published validation study of the QHES demonstrated the validity of this new instrument. The resulting QHES scores in the case study of GERD papers ranged from 43 to 91 with a mean of 63.6 (SD=14.7). Approximately 27% of the studies rated had scores less than 50, and 27% had scores above or equal to 75. All 30 studies made conclusions and recommendations and justified them based on their study results. Most studies used appropriate cost and health outcome measures. Very few studies stated the perspective of their analysis and reasons for its selection. The majority of the studies did not perform incremental analysis. CONCLUSION: An examination of the QHES validation study and the case study in GERD suggests that there is a rationale and potential utility to use a quality scoring system for cost-effectiveness studies. The QHES may play an important role in discriminating higher-quality cost-effectiveness information to enhance decision making. The QHES can also serve as a guideline for conducting and reporting future cost-effectiveness studies, as an aid in the editorial process, and for stratification in systematic reviews. Complex decisions regarding resource allocation rarely rely solely on economic considerations but do increasingly use health economic analyses. To the extent that such analyses are used, the QHES may help ensure that higher-quality analyses receive more analytic attention and greater weight in the decision-making process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.18553/jmcp.2003.9.1.53

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Users' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 3,083
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455 · cited 1×
“Weinstein et al., 1996.”
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Are Guidelines Following Guidelines?
Shaneyfelt, T. M., Mayo‐Smith, M. F., & Rothwangl, J. (1999) · JAMA · doi:10.1001/jama.281.20.1900 · Cited by 853
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819

Flagged first, then by citations

Show all 76 references

2 of the 76 references couldn’t be matched to a known paper.

Research works printed but not linked: 19

Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guide- lines? The methodological quality of clinical practice guidelines in the peer- reviewed medical literature. JAMA. 1999;281:1900-05.
Drummond MF, Richardson WS, O'Brien BJ, et al. User' s guide to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1997; 277:1552-57.
O'Brien B, Heyland D, Richardson WS, et al. User' s guide to the medical litera- ture. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA.1997; 277:1802-06.
Sonnenberg A, Inadomi JM, Becker LA. Economic analysis of step-wise treat- ment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1003-13.
Stalhammar NO. Assessing the cost-effectiveness of medical treatments in Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis. Scand J Gastroenterol Suppl. 1993;199:8-13.
Bate C, Richardson P. Cost-effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ. 1994;7:81-97.
Bate C, Hungin A, Wilcock C. Cost-effective management of gastroesophageal reflux disease in general practice. Br J Med Econ. 1993;6:81-90.
Bate C, Green J, Taylor M. Cost-effective prophylaxis against the recurrence of benign oesophageal stricture. Br J Med Econ. 1995;8:97-107.
Bate C, Richardson P. A one-year model for the cost-effectiveness of treating reflux oesophagitis. Br J Med Econ. 1992;2:5-11.
Bate C. Cost-effectiveness of omeprazole in the treatment of reflux oesophagi- tis. Br J Med Econ. 1991;1:53-61.
Bate C, Richardson P. Symptomatic assessment and cost effectiveness of treat- ments for reflux oesophagitis: comparisons of omeprazole and histamine H2- receptor antagonists. Br J Med Econ. 1992;2:37-48.
Green J, Bate C, Copeman M. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis. Br J Med Econ. 1995;8:37-48.
Jonsson B, Stalhammar NO. The cost-effectiveness of omeprazole and raniti- dine in intermittent and maintenance treatment of reflux oesophagitis-the case of Sweden. Br J Med Econ. 1993;6:111-26.
Phillips C, Moore A. Trial and error-an expensive luxury: economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. Br J Med Econ. 1997;11:55-63.
Bate C, Richardson P. Cost-effectiveness of 20 mg and 40 mg of omeprazole in oesophageal reflux disease. Br J Med Econ. 1993;6:59-66.
Torrance GW, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics. 1996;9:535-59.
Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology. Ann Intern Med. 1995;123:61-70.
Drummond M, O'Brien B, Stoddart G, Torrance GW. Critical Assessment of Economic Evaluation. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford Medical Publications; 1997:27-51.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-83.

Sorted by citations

Items 201–300 of 366

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Rezapour, A., Behroozi, Z., Nasirzadeh, M., Rezaeian, M., Barzegar, M., Tashakori-Miyanroudi, M., Sayyad, A., & Souresrafil, A. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01092-1 · Cited by 10
Non-communicable Disease Prevention
(eds.), A. J. C., Teerawattananon, Y., Archer, R. A., & Isaranuwatchai, W. (2019) · Open Book Publishers · doi:10.11647/obp.0195 · Cited by 10
Measles outbreak investigation process in low- and middle-income countries: a systematic review of the methods and costs of contact tracing
Mbivnjo, E. L., Lynch, M., & Huws, J. C. (2021) · Journal of Public Health · doi:10.1007/s10389-021-01590-2 · Cited by 9
Costs of implementing community-based intervention for HIV testing in sub-Saharan Africa: a systematic review
Uzoaru, F., Nwaozuru, U., Ong, J. J., Obi, F. A., Obiezu‐Umeh, C., Tucker, J. D., Shato, T., Mason, S., Carter, V., Manu, S., et al. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00177-y · Cited by 10
Economic Evaluation of Monoclonal Antibodies in Metastatic Colorectal Cancer: A Systematic Review
Koilakou, S., & Petrou, P. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-021-00560-4 · Cited by 9
The economics of TAVI: A systematic review
Petrou, P. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101173 · Cited by 10
A systematic review of economic evaluations of clinical pharmacy Services in the United States: 2018–2022
Santos, B. D. L., Kim, M., Alsharif, A. H., Gharib, A. M., Kim, J., Binu, B., Touchette, D. R., & Pérez, A. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70034 · Cited by 8
Systematic literature review of health economic models developed for multiple myeloma to support future analyses
Choon-Quinones, M., Zelei, T., Németh, B., Tóth, M., Jia, X. Y., Barnett, M., Keown, P. A., Durie, B. G. M., Harousseau, J., Hose, D., et al. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2144056 · Cited by 8
A Scoping Review of Economic Evaluations to Inform the Reorientation of Preventive Health Services in Australia
Taylor, R., Sullivan, D., Reeves, P., Kerr, N., Sawyer, A., Schwartzkoff, E., Bailey, A. W., Williams, C. M., & Hure, A. J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20126139 · Cited by 11
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models
Ahmed, A., Dujaili, J. A., Chuah, L., Hashmi, F. K., Le, L. K., Khanal, S., Awaisu, A., & Chaiyakunapruk, N. (2023) · Applied Health Economics and Health Policy · doi:10.1007/s40258-023-00818-4 · Cited by 8
The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence
Yang, M., Patil, D. S., Tufail, W., & Issa, A. M. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2013.838023 · Cited by 8
Autologous Stem Cells in Cervical Spine Fusion
Hsieh, P. C., Chung, A. S., Brodke, D. S., Park, J., Skelly, A. C., Brodt, E., Chang, K., Buser, Z., Meisel, H. J., Yoon, S. T., et al. (2020) · Global Spine Journal · doi:10.1177/2192568220948479 · Cited by 8
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis
Lu, Z. K., Xiong, X., Lee, T., Wu, J., Yuan, J., & Jiang, B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.700012 · Cited by 7
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Gao, W., Muston, D., Monberg, M., McLaurin, K. K., Hettle, R., Szamreta, E. A., Swallow, E., Zhang, S., Kalemaj, I., Signorovitch, J., et al. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00949-9 · Cited by 8
Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?
Fens, T., Zhou, G., Postma, M. J., van Puijenbroek, E., & van Boven, J. F. M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873953 · Cited by 8
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence
Veldman, H. D., de Bot, R. T. A. L., Heyligers, I. C., Boymans, T. A. E. J., & Hiligsmann, M. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1878880 · Cited by 8
Cost-utility studies in upper limb orthopaedic surgery
Rajan, P. V., Qudsi, R. A., Dyer, G. S. M., & Losina, E. (2018) · The Bone & Joint Journal · doi:10.1302/0301-620x.100b11.bjj-2018-0246.r1 · Cited by 8
The Role of Decision Analytic Modeling in the Health Economic Assessment of Spinal Intervention
Edwards, N. C., Skelly, A. C., Ziewacz, J. E., Cahill, K., & McGirt, M. J. (2014) · Spine · doi:10.1097/brs.0000000000000567 · Cited by 8
Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review
Martin‐Misener, R., Harbman, P., Donald, F., Reid, K., Kilpatrick, K., Carter, N., Bryant‐Lukosius, D., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2021) · doi:10.32920/14637459.v1 · Cited by 8
Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia
Wang, M., Jiang, S., Li, B., Parkinson, B., Lu, J., Tan, K., Gu, Y., & Li, S. (2024) · Global Health Research and Policy · doi:10.1186/s41256-024-00382-x · Cited by 7
Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment
Droeghaag, R., Schuermans, V. N. E., Hermans, S. M. M., Smeets, A. Y. J. M., Caelers, I. J. M. H., Hiligsmann, M., Evers, S., van Hemert, W. L. W., & van Santbrink, H. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067871 · Cited by 8
Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses
Sanyal, C., & Husereau, D. (2019) · Value in Health · doi:10.1016/j.jval.2019.08.013 · Cited by 8
A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
Byun, J., Park, S., Ng, B. P., Liu, Y., Kim, C.-R., & Park, C. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2095203 · Cited by 7
Quality of health economic evaluations for the ACC/AHA stable ischemic heart disease practice guideline: A systematic review
Stevens, E. R., Farrell, D., Jumkhawala, S. A., & Ladapo, J. A. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.06.013 · Cited by 7
The Role of Review and Synthesis Methods in Decision Models
Marsh, K. (2010) · doi:10.1002/9781444320398.ch2 · Cited by 7
Screening for chronic kidney disease: a systematic review of emerging evidence and perspectives
Li, J., Zhao, M., & He, Q. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2572353 · Cited by 9
Accounting for Intergenerational Cascade Testing in Economic Evaluations of Clinical Genomics: A Scoping Review
Zischke, J., White, N. M., & Gordon, L. G. (2021) · Value in Health · doi:10.1016/j.jval.2021.11.1353 · Cited by 6
Economic Evaluation of Oral Cancer Screening Programs: Review of Outcomes and Study Designs
Raman, S., Shafie, A. A., Tan, B. Y., Abraham, M. T., Kiong, S. C., & Cheong, S. C. (2023) · Healthcare · doi:10.3390/healthcare11081198 · Cited by 6
Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review
Nédellec, E., Pineau, J., Prognon, P., & Martelli, N. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-018-0429-z · Cited by 6
Maternal Diet Quality, Body Mass Index and Resource Use in the Perinatal Period: An Observational Study
Szewczyk, Z., Weaver, N., Rollo, M. E., Deeming, S., Holliday, E. G., Reeves, P., & Collins, C. E. (2020) · Nutrients · doi:10.3390/nu12113532 · Cited by 8
Cost-effectiveness of stereotactic body radiotherapy in the treatment of non–small-cell lung cancer (NSCLC): a systematic review
Sun, H., Jin, C., Wang, H., Hu, S., Chen, Y., & Wang, H. (2022) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2022.2050217 · Cited by 6
A systematic review on the cost‐effectiveness of the computer‐assisted orthopedic system
Li, H., Zhuang, T., Wu, W., Gan, W., Wu, C., Peng, S., Huan, S., & Liu, N. (2022) · Health care science · doi:10.1002/hcs2.23 · Cited by 6
Cost-Effectiveness of Glucosamine in Osteoarthritis Treatment: A Systematic Review
Vo, N. X., Le, N. N. H., Chu, T. D. P., Pham, H. L., Dinh, K. X. A., Che, U. T. T., Ngo, T. T. T., & Bui, T. T. (2023) · Healthcare · doi:10.3390/healthcare11162340 · Cited by 6
Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations
Gajic‐Veljanoski, O., Li, C., Schaink, A. K., Guo, J., Higgins, C., Shehata, N., Okun, N. B., de Vrijer, B., Pechlivanoglou, P., Ng, V., et al. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.07.014 · Cited by 6
Cost-effectiveness of PSMA-PET imaging technology in diagnosing and staging of prostate cancer: a systematic review
Sanyal, C., & Rendon, R. A. (2026) · Therapeutic Advances in Urology · doi:10.1177/17562872261436874 · Cited by 5
Health Economic Evaluations of Hip and Knee Interventions in Orthopaedic Sports Medicine: A Systematic Review and Quality Assessment
Primeau, C. A., Zomar, B. O., Somerville, L. E., Joshi, I., Giffin, J. R., & Marsh, J. D. (2021) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967120987241 · Cited by 5
1. Introduction
Isaranuwatchai, W., Archer, R. A., & Culyer, A. J. (2019) · Open Book Publishers · doi:10.11647/obp.0195.01 · Cited by 5
Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review
Chan, V. K. Y., Yang, R., Wong, I. C. K., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.891149 · Cited by 5
Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure
Nam, K.-A., Cho, D., Kim, H.-J., Kwon, B., Yoon, Y., Park, C., Kim, E.-S., Youn, J., & Park, S. (2023) · Clinical Drug Investigation · doi:10.1007/s40261-023-01283-6 · Cited by 5
Economic evaluation of automated external defibrillator deployment in public settings for out-of-hospital cardiac arrest: a systematic review
Arabloo, J., Ahmadizadeh, E., Rezapour, A., Ehsanzadeh, ‬. J., Alipour, V., Peighambari, M. M., Asiabar, A. S., & Souresrafil, A. (2024) · Expert Review of Medical Devices · doi:10.1080/17434440.2024.2354472 · Cited by 5
A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris
Vellopoulou, K., Kourlaba, G., Maniadakis, N., & Vardas, P. E. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.140 · Cited by 5
Health economic modelling in Cystic Fibrosis: A systematic review
Mohindru, B., Turner, D., Sach, T., Bilton, D., Carr, S. B., Archangelidi, O., Bhadhuri, A., & Whitty, J. A. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.01.007 · Cited by 5
Current State of Health Economic Analyses for Low-Grade Glioma Management: A Systematic Review
Tuohy, K. J., Fernandez, A., Hamidi, N., Padmanaban, V., & Mansouri, A. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.05.112 · Cited by 5
Cost-Utility Analyses in US Orthopaedic Foot and Ankle Surgery: A Systematic Review
Karhade, A. V., & Kwon, J. Y. (2018) · Foot & Ankle Specialist · doi:10.1177/1938640018782588 · Cited by 5
A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs
Ribeiro, I., Marques, F. B., Alves, D. G., & Alves, C. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1579646 · Cited by 5
Global Economic Burden of Spinal Muscular Atrophy: A Systematic Literature Review
Elshahawy, R., Elezbawy, B., Ashmawy, R., Elshahawy, R., Mahmoud, Y. S., Korra, N., Abaza, S., Alnajjar, A., Alabdulkarim, H. A., Al‐Omar, H. A., et al. (2025) · Cureus · doi:10.7759/cureus.81023 · Cited by 4
Systematic Review and Quality Assessment of Health Economic Evaluation Studies (2007–2019) Conducted in South Korea
Yi, S., Hong, J., Yoon, H., Lim, Y.-N., & Bae, E.-Y. (2022) · Applied Health Economics and Health Policy · doi:10.1007/s40258-022-00746-9 · Cited by 4
Comparison between Tubeless Mini-Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery for the Treatment of 2 to 3Cm Renal Lithiasis
Lee, Y.-C., Jou, Y., Cheng, M.-C., Shen, C., & Lin, C.-T. (2022) · Urological Science · doi:10.4103/uros.uros_54_21 · Cited by 4
Antagonistas del factor de necrosis tumoral (TNF) en la enfermedad inflamatoria intestinal pediátrica: Una revisión sistemática
Martín-García, P., Alonso‐Arroyo, A., & Catalá-López, F. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.02.006 · Cited by 4
A systematic review of psychosocial challenges for MSM living with HIV among diverse and intersecting minorities
Amato, A. T., & Émond, G. (2023) · The Canadian Journal of Human Sexuality · doi:10.3138/cjhs-2022-0048 · Cited by 4
The Value of Social Work to Health, Health Systems, and Interprofessional Teams: A Scoping Review
Ross, A. M., Jashinski, J., Lombardo, M. Z., Keane, J., & Wilkinson, G. W. (2024) · Social Work Research · doi:10.1093/swr/svad022 · Cited by 4
Evaluations of Morphine and Fentanyl for Mechanically Ventilated Patients With Respiratory Disorders in Intensive Care: A Systematic Review of Methodological Trends and Reporting Quality
Abushanab, D., Alsoukhni, O., & Al‐Badriyeh, D. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2018.11.001 · Cited by 4
Systematic evidence of health economic evaluation of drugs for postmenopausal osteoporosis: A quality appraisal
Azharuddin, M., Adil, M., Khan, R. A., Ghosh, P., Kapur, P., & Sharma, M. (2020) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2020.05.006 · Cited by 4
Cost-effectiveness of brentuximab vedotin in Hodgkin lymphoma: a systematic review
Arabloo, J., Azari, S., Gorji, H. A., Rezapour, A., Alipour, V., & Ehsanzadeh, ‬. J. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03557-6 · Cited by 4
Requirements for a Successful Drug Launch in Small Markets: A Pilot Study in Lebanon
Ramadan, B., Metni, M., Hamadeh, G. N., Kurdi, M., & Karam, R. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2019.01.006 · Cited by 4
The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes
Barrera, F. J., Toloza, F. J. K., Ponce, O. J., Hernández, J. A. Z., Prokop, L. J., Shah, N. D., Guyatt, G. H., Rodríguez‐Gutiérrez, R., & Montori, V. M. (2020) · Endocrine · doi:10.1007/s12020-020-02489-w · Cited by 4
A Systematic Review of Economic Analyses Studying Rituximab in R-CHOP Therapy in Patients with Non-Hodgkin Lymphoma
Yoder, J. L., & Kamal, K. M. (2009) · The Open Cancer Immunology Journal · doi:10.2174/1876401000902010001 · Cited by 4
Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals
Woersching, A. L., Borrego, M. E., & Raisch, D. W. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016662893 · Cited by 4
Cost-Effectiveness of Endovascular Aneurysm Repair Versus Open Surgical Repair for Ruptured Abdominal Aortic Aneurysms: A Systematic Review
Dolatshahi, Z., Mezginejad, F., Nargesi, S., & Saliminejad, M. (2021) · Iranian Journal of Radiology · doi:10.5812/iranjradiol.109932 · Cited by 4
Cost effectiveness of fall prevention programmes for older adults
Benedetto, V., Hill, J. E., & Harrison, J. (2022) · British Journal of Community Nursing · doi:10.12968/bjcn.2022.27.11.530 · Cited by 3
Basics of health economics for clinical trials in orthopaedic trauma
Walter, N., Hierl, K., Rupp, M., & Alt, V. (2023) · Injury · doi:10.1016/j.injury.2023.110878 · Cited by 3
Cost-Effectiveness Analysis of Regorafenib versus Other Third-Line Treatments for Metastatic Colorectal Cancer
Zhong, J., Liu, Y., Qian, F., Huang, D., Gong, W., & Zou, J. (2024) · Cancer Management and Research · doi:10.2147/cmar.s464831 · Cited by 3
Cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing device for treatment of heavy menstrual bleeding: a systematic review
Zavare, A. S. N., Rezapour, A., Souresrafil, A., Rouholamin, S., & Nassiri, S. (2024) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2024.2417014 · Cited by 3
Cost-effectiveness of Telemedicine Intervention for Acute Myocardial Infarction: A Systematic Review
Abedinejad, M., Hadian, M. R., Behrooj, S., Faradonbeh, S. B., & Saniee, N. (2024) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.38.103 · Cited by 3
Economic evaluations of oral medications for breast cancer treatment in the U.S.: a systematic review with a focus on cost-effectiveness threshold
Park, S., Chun, H. K., & Park, C. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1680289 · Cited by 3
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumor: A Systematic Review
Feng, M., Yang, Y., Liao, W., & Li, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.768765 · Cited by 3
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review
Tefera, B. B., Demsie, D. G., Yehualaw, A., Tafere, C., Feyisa, K., Yismaw, M. B., Kefale, B., & Yilma, Z. (2023) · PharmacoEconomics - Open · doi:10.1007/s41669-023-00433-y · Cited by 3
Economic Evidence in Occupational Therapy: A Rapid Review
Freeman, A. R., Larivière, N., Baillet, J., Beauchemin, R., Lavoie-Trudeau, É., Martel, M., & St-François, M. (2025) · Canadian Journal of Occupational Therapy · doi:10.1177/00084174241306983 · Cited by 3
Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations
Mehta, M. N., & Nerurkar, R. (2017) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479017731583 · Cited by 3
Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship
Sofjan, A. K., Musgrove, R. J., & Garey, K. W. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0257-2 · Cited by 3
A methodological analysis of systematic reviews of cost-effectiveness in screening, diagnosis, and treatment of colorectal cancer
Zabala, M. V., & Bachelet, V. C. (2026) · Health Economics Review · doi:10.1186/s13561-026-00774-4 · Cited by 2
Cost-Effectiveness of Arthroplasty Management in Hip and Knee Osteoarthritis: a Quality Review of the Literature
Primeau, C. A., Joshi, I., Zomar, B. O., Somerville, L. E., Philpott, H. T., McHugh, D. D., Lanting, B. A., Vasarhelyi, E. M., & Marsh, J. D. (2020) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-020-00157-8 · Cited by 2
Systematic review of the cost-effectiveness of nurse practitioners and clinical nurse specialists: What is the quality of the evidence?
Donald, F., Kilpatrick, K., Reid, K., Carter, N., Martin‐Misener, R., Bryant‐Lukosius, D., Harbman, P., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2021) · doi:10.32920/14637009.v1 · Cited by 2
Economic Evaluation of Type 2 Diabetes Mellitus Interventions in Low- and Middle-Income Countries: A Systematic Review of the Literature
Lum, K. Y., Oppong, R., & Kigozi, J. (2022) · Asia Pacific Journal of Public Health · doi:10.1177/10105395221122643 · Cited by 2
Economic evaluations of treatment of depressive disorders in adolescents: Protocol for a scoping review
Courtney, D., Mason, J., Amani, B., Rodak, T., Szatmári, P., Henderson, J. L., & de Oliveira, C. (2024) · Early Intervention in Psychiatry · doi:10.1111/eip.13498 · Cited by 2
Cost-effectiveness of ace inhibitors versus ARBs in heart failure management
Elendu, C., Amaechi, D. C., Elendu, T. C., Amaechi, E. C., Elendu, I. D., Jingwa, K. A., Chiegboka, S. F., Bhadana, U., Abdelatti, A. M. S., Ikeji, I. V., et al. (2024) · Medicine · doi:10.1097/md.0000000000039496 · Cited by 2
Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review
de Oliveira, C., Mason, J., Amani, B., Rodak, T., Szatmári, P., Henderson, J. L., & Courtney, D. (2025) · Value in Health · doi:10.1016/j.jval.2025.02.005 · Cited by 2
Economic Evaluation of Acute Appendicitis Therapeutic Interventions: A Systematic Review
Gorji, H. A., Moeini, S., Sheikhrobat, M. V., Rezapour, A., Souresrafil, A., & Barzegar, M. (2025) · Health Science Reports · doi:10.1002/hsr2.70815 · Cited by 2
Cost-Effectiveness of Nurse Practitioners
Huang, L. (2015) · ScholarlyCommons (University of Pennsylvania) · Cited by 2
Does Direct-care Staffing Impact Nursing Home Outcomes? A Systematic Review
Schlage, V., & Blankart, C. R. (2016) · Die Unternehmung · doi:10.5771/0042-059x-2016-3-291 · Cited by 2
Cervical Cancer Epidemiology, Prevention and Screening among Women Living with HIV in the Americas region: A Systematic Review Protocol
Caicedo‐Martínez, M., Ordóñez‐Reyes, C., Fernández-Deaza, G. P., Murillo, R., Mello, M. B., & Nuche‐Berenguer, B. (2020) · Universitas Médica · doi:10.11144/javeriana.umed61-4.ccep · Cited by 2
Current Orthopaedic Health Economic Literature: Quality Is High but Ethical and Societal Perspectives Are Lacking
Lamplot, J. D., Sharma, A. K., Sullivan, S. W., Allen, A. A., & Nwachukwu, B. U. (2021) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2021.01.026 · Cited by 2
Self-citation
The performance and publication of cost-utility analyses in plastic surgery: Making our specialty relevant
Thoma, A., & Ignacy, T. A. (2012) · Plastic Surgery · doi:10.4172/plastic-surgery.1000771 · Cited by 2
Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review
Martin‐Misener, R., Harbman, P., Donald, F., Reid, K., Kilpatrick, K., Carter, N., Bryant‐Lukosius, D., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2021) · doi:10.32920/14637459 · Cited by 2
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review
Mohammadnezhad, G., Azadmehr, B., & Yousefi, N. (2022) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2022.2130761 · Cited by 2
Evaluación Económica en Medicina (III). Revisión de las directrices para la realización de evaluaciones económicas. Instrumentos de valoración de la calidad metodológica
Costi, M. P., de Dios, J. G., & del Castillo, J. A. S. (2010) · Dialnet (Universidad de la Rioja) · Cited by 2
Contingent Valuation Studies in Orthopaedic Surgery: A Health Economic Review
Nwachukwu, B. U., Eliasberg, C. D., Hamid, K. S., Fu, M. C., Bach, B. R., Allen, A. A., & Albert, T. J. (2018) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-018-9610-z · Cited by 2
Economic evaluations of commonly used structured psychotherapies for major depressive disorder and generalized anxiety disorder: A systematic review.
Gajic‐Veljanoski, O., Sanyal, C., McMartin, K., Xie, X., Walter, M. C., Higgins, C., Sikich, N., Dhalla, I. A., & Ng, V. (2018) · Canadian Psychology/Psychologie canadienne · doi:10.1037/cap0000155 · Cited by 3
Dollars and Sense
Reider, B. J. (2015) · The American Journal of Sports Medicine · doi:10.1177/0363546515588309 · Cited by 2
Pharmacoeconomics of cardiovascular disease prevention
Stevanović, J. (2015) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in Low and Middle-Income Countries: A Systematic Review
Souresrafil, A., Abutorabi, A., Peighambari, M. M., Noohi, F., & Haghjoo, M. (2022) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.36.6 · Cited by 1
Costs of Palliative Care in Oncological and Non-Oncological Patients with Different Types of Ambulatory-Based Attention: Cost-Study Protocol
Perea-Bello, A. H., Trapero‐Bertran, M., & Dürsteler, C. (2024) · Diseases · doi:10.3390/diseases12100243 · Cited by 1
Untackling the economics of multiple sclerosis: A systematic review of economic evaluations of disease-modifying therapies indicated for multiple sclerosis
Petrou, P. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106161 · Cited by 2
Economic impact of a digital tobacco cessation program: healthcare savings and productivity gains in a self-insured manufacturing company
Brault, M. W., Rein, D. B., & Graham, A. L. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2529721 · Cited by 1
Cost-effectiveness of MRI strategies for early prostate cancer detection: a systematic review
Zavare, A. S. N., Shahkoohi, A. N., Khalili, F., Rezapour, A., Afshari, S., Alipour, S., & Asiabar, A. S. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2543464 · Cited by 1
Disease-modifying treatments in paroxysmal nocturnal hemoglobinuria: a systematic review of economic evaluations
Moradi, S., Khajeamiri, Y., Zandi, S., Keramati, M., & Mohammadnezhad, G. (2025) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-025-00702-z · Cited by 2
Assessing the economic burden of complicated urinary tract infection: A systematic literature review
Broughton, E. I., Colosia, A. D., Bektas, M., Kuper, K. M., & Kotb, R. E. M. (2025) · The European Journal of Health Economics · doi:10.1007/s10198-025-01846-8 · Cited by 1
A qualitative systematic review and quality assessment of pharmacoeconomic evaluations on Chinese Herbal Medicine from 2020 to 2025
Cai, Y., Tang, Q., Lin, T., Wang, D., Hu, M., & Yang, N. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1738097 · Cited by 1
Introduction to the Technical Issues of Economic Evaluation
Fragoulakis, V., Mitropoulou, C., Williams, M. S., & Patrinos, G. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801497-4.00004-7 · Cited by 1
Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
Roberts, M. H., Borrego, M. E., Kharat, A. A., Marshik, P. L., & Mapel, D. W. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1148602 · Cited by 1

Authors: Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W.
ORCID: Sullivan, Sean D.
Neumann, Peter J.
Hay, Joel W.
Venue: Journal of Managed Care Pharmacy
Publisher: Academy of Managed Care Pharmacy
Published: 2003-01
Volume: 9
Issue: 1
Pages: 53-61
ISSN: 1083-4087 (ISSN-L)
1944-706X
DOI: 10.18553/jmcp.2003.9.1.53
PMC: PMC10437166
OpenAlex: W2130921523
Cited by: 366
References: 76
Citations by year: 2026: 14 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 25 · 2021: 39 · 2020: 27 · 2019: 35 · 2018: 17 · 2017: 20 · 2016: 16 · 2015: 21 · 2014: 24 · 2013: 18 · 2012: 11
FWCI: 9.62
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Managed Care Pharmacy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords: instrument validation, gastroesophageal reflux disease, healthcare decision-making, resource allocation, reporting guidelines, systematic reviews
MeSH terms: Cost-Benefit Analysis, Delivery of Health Care, Humans, United States, Economics, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks